2Gaghu G,Collard HR,Egan JJ,et al. An Official ATS/ERS/JRS/ALAT Statement : idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management[J]. Am J Respir Crit Care Med ,2011,183 (6) : 788-824.
4GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
5Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
6Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
6Agis T, Vaggelis H, Triantafillos V, et al. Comparative Ex- pression Profiling in Pulmonary Fibrosis Suggests a Role of Hypoxia ~ inducible Factor - I in Disease Pathogenesis. Re- spir Crit Care Med,2007,176(8) :1 108 ~ 1 119.
7高社琪,王培勇,周其全,等.高原病理生理学.北京:人民卫生出版社,2006,76～87.
8Gaghu G, Collard HR , Egan JJ , et al. An Official ATS/ ERS/JRS/ALAT Statement: Idiopathic pulmonary fibrosis: evidence- based guidelines for diagnosis and management. Am J Respir Crit Care Med,2011,183 (6) :788 ~ 824.
